MDT Stock: Price, Earnings History and SEC Filings
Medtronic plc (MDT) last traded at $96.54, down 0.59% on the latest session and up 11.9% over the past month. In its most recent reported quarter (Jul 2026) earnings per share were $1.45 against an analyst estimate of $1.39, a beat of 4.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MDT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jul 2026 | Sep 1, 2026 | $1.45 | $1.39 | +4.32% |
| Apr 2026 | Jun 3, 2026 | $1.55 | $1.54 | +0.65% |
| Jan 2026 | Feb 17, 2026 | $1.36 | $1.33 | +2.26% |
| Oct 2025 | Nov 18, 2025 | $1.36 | $1.31 | +3.82% |
MDT beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How MDT reacts to earnings
Across its last 8 earnings releases, MDT moved 3.8% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-09-01 | Before open | +1.53% |
| 2026-06-03 | Before open | +5.69% |
| 2026-02-17 | Before open | -3.10% |
| 2025-11-18 | Before open | +4.69% |
| 2025-08-19 | Before open | -3.14% |
| 2025-05-21 | Before open | -2.27% |
| 2025-02-18 | Before open | -7.26% |
| 2024-11-19 | Before open | -2.96% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
MDT financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $36.4B | $4.8B | $5.4B | 13.2% | $3.73 |
| 2025 | $33.5B | $4.7B | $5.2B | 13.9% | $3.61 |
| 2024 | $32.4B | $3.7B | $5.2B | 11.4% | $2.76 |
| 2023 | $31.2B | $3.8B | $4.6B | 12.0% | $2.82 |
| 2022 | $31.7B | $5.0B | $6.0B | 15.9% | $3.73 |
| 2021 | $30.1B | $3.6B | $4.9B | 12.0% | $2.66 |
| 2020 | $28.9B | $4.8B | $6.0B | 16.6% | $3.54 |
| 2019 | $30.6B | $4.6B | $5.9B | 15.2% | $3.41 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for MDT
- 8-K · Oct 19, 2026Officer or director change, Shareholder vote, Regulation FD disclosure
- 8-K · Sep 17, 2026Other events, Financial statements and exhibits
- 10-Q · Sep 3, 2026
- 8-K · Sep 1, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Aug 17, 2026
- 10-K · Jun 18, 2026
- 8-K · Jun 3, 2026Results of operations, Financial statements and exhibits
- 8-K · May 18, 2026Officer or director change, Financial statements and exhibits
- 8-K · Apr 27, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Mar 24, 2026Regulation FD disclosure
Insider filing activity
MDT insiders filed 15 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
MDT news
- Medtronic (MDT) Posted Positive Real World Ablation DataNov 1, 2026 · finance.yahoo.com
- Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?Nov 1, 2026 · fool.com
- If a Bear Market Is Coming, History Says These Stocks Could Be the Smartest to OwnOct 31, 2026 · fool.com
- Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036Oct 30, 2026 · finance.yahoo.com
- Alphatec Sinks 36% on Guidance Cut as Q3 Revenue Falls ShortOct 30, 2026 · tikr.com
- JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Oct 30, 2026 · finance.yahoo.com
- Has The Story Under Johnson & Johnson Stock Run Out?Oct 30, 2026 · trefis.com
- Why the Market Dipped But Medtronic (MDT) Gained TodayOct 29, 2026 · finance.yahoo.com
About Medtronic plc
Medtronic plc (MDT) is a US-listed public company on NYSE. The SEC classifies its business as Electromedical & Electrotherapeutic Apparatus. Its fiscal year ends in April.